Mirion Technologies (NYSE:MIR) Stock Price Down 7.1% – What’s Next?

Mirion Technologies, Inc. (NYSE:MIR)’s stock price fell 7.1% during trading on Monday. The company traded as low as $14.48 and last traded at $14.4850. 2,542,441 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 3,720,201 shares. The stock had previously closed at $15.59.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on MIR. B. Riley Financial dropped their target price on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Jefferies Financial Group initiated coverage on shares of Mirion Technologies in a report on Thursday, September 3rd. They issued a “buy” rating and a $20.00 target price on the stock. The Goldman Sachs Group reiterated a “buy” rating and set a $23.00 price target on shares of Mirion Technologies in a report on Wednesday, July 29th. Weiss Ratings raised shares of Mirion Technologies from a “sell (d)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Finally, Morgan Stanley lowered their price objective on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a research note on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Mirion Technologies has an average rating of “Moderate Buy” and an average target price of $25.56.

Mirion Technologies Stock Performance

The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.63 and a current ratio of 3.20. The business’s 50-day moving average is $15.74 and its 200-day moving average is $17.44. The company has a market capitalization of $3.58 billion, a PE ratio of 143.62 and a beta of 1.05.

Mirion Technologies (NYSE:MIR) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. Mirion Technologies had a net margin of 2.39% and a return on equity of 6.59%. The business had revenue of $266.80 million for the quarter, compared to analysts’ expectations of $269.32 million. During the same quarter in the prior year, the company earned $0.11 earnings per share. The business’s revenue was up 19.7% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, research analysts anticipate that Mirion Technologies, Inc. will post 0.55 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MIR. Tidal Investments LLC raised its stake in Mirion Technologies by 8.5% during the second quarter. Tidal Investments LLC now owns 840,683 shares of the company’s stock valued at $15,073,000 after buying an additional 65,670 shares during the last quarter. Nykredit A S purchased a new stake in shares of Mirion Technologies in the second quarter worth $137,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Mirion Technologies during the second quarter valued at $276,000. B. Metzler seel. Sohn & Co. AG bought a new position in shares of Mirion Technologies during the second quarter valued at $2,597,000. Finally, Wellington Management Group LLP raised its position in shares of Mirion Technologies by 31.2% in the 2nd quarter. Wellington Management Group LLP now owns 1,098,987 shares of the company’s stock worth $19,705,000 after purchasing an additional 261,175 shares during the last quarter. Institutional investors own 78.51% of the company’s stock.

About Mirion Technologies

Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.

The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.